Oxford Biomedica Stock Forecast for 2023 - 2025 - 2030
Updated on 05/04/2024
Oxford Biomedica Stock Forecast and Price Target
The average price target for Oxford Biomedica's stock set by two recognized analysts recently is £3.93, which would result in a potential upside of approximately 19.82% if it reached this mark. The estimation is based on a high estimate of £7.40 and a low estimate of £2.10. If you are interested in OXB stock, you should also look at its competitors.
19.82% Upside
Oxford Biomedica Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Oxford Biomedica's Price has grown, moving from £0.00 to £0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will jump to £3.48 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.
Oxford Biomedica Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Oxford Biomedica's Revenue has grown, moving from £87.73M to £89.54M – an increase of 2.06%. In the next year, analysts predict that Revenue will jump to £120.55M – up 34.63% from the current level. Looking ahead to seven years, experts forecast that Revenue will grow by 241.64%.
.jpg)
Oxford Biomedica EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Oxford Biomedica's EBITDA has decreased from £3.60M to £-57.27M – a 1690.83% drop. For the following year, the 2 analysts predict that Oxford Biomedica's EBITDA will drop by 86.26%, reaching £-7.87M. Over the next seven years, experts anticipate that EBITDA growth for Oxford Biomedica will be 176.50%.
Oxford Biomedica EBIT Forecast for 2023 - 2025 - 2030
Oxford Biomedica's EBIT has grown in the last three years, jumping from £-4.86M to £-85.98M – an increase of 1669.14%. In the following year, the 6 analysts surveyed believe that Oxford Biomedica's EBIT will decrease by 54.68%, reaching £-38.97M. According to professionals, by 2030, Oxford Biomedica's EBIT will have decreased by 160.48%, falling down to £52.00M.
Oxford Biomedica EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Oxford Biomedica's EPS has grown, moving from £-0.07 to £0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will jump to £-0.47 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.
.jpg)